{"id":49651,"date":"2018-10-02T10:15:20","date_gmt":"2018-10-02T14:15:20","guid":{"rendered":"https:\/\/asweetlife.org\/?p=49651"},"modified":"2019-04-11T04:02:04","modified_gmt":"2019-04-11T08:02:04","slug":"niddk-funds-development-of-dual-hormone-patch-pump-for-people-with-diabetes","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=49651","title":{"rendered":"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes"},"content":{"rendered":"<p><em><strong>Miniaturized system will allow accurate insulin and glucagon dosing in a discreet, low profile patch pump for people with Type 1 diabetes.<\/strong><\/em><\/p>\n<p>SFC Fluidics announced it has received a $1.4 million grant from the National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health to develop a patch pump that can deliver both insulin and glucagon to people with Type 1 diabetes. Glucagon is a hormone that helps the liver release glucose in order to raise blood sugar levels. \u00a0<\/p>\n<p>The small system in development is the size of existing insulin-only patch pumps, and\u00a0<a href=\"http:\/\/www.sfc-fluidics.com\/09202018\">SFC\u2019s proposed patch pump system<\/a> will have the necessary safety features and dose accuracy to allow automated insulin and glucagon dosing.\u00a0Another proprietary feature of the proposed system is a flow confirmation sensor that determines whether dose administration has occurred as expected in real-time. This sensor will quickly alert to any problems within the patch pump such as occlusions, leaks, depleted drug supply, accidental misloading, and any mechanical\/electrical failure. According to Dr. Forrest Payne, the Principal Investigator on the project, \u201cThe suite of patents and patent applications that covers SFC Fluidics\u2019 system &#8211; from the pump to the valves to the sensors &#8211; will allow for development of a next generation dual-hormone patch pump that combines safety, convenience and small size with excellent accuracy and precision.\u201d<\/p>\n<p>\u201cWe think the proposed system will be especially attractive to adolescents with Type 1 diabetes and will serve the broader diabetic community as well. What\u2019s more, we see the dual hormone drug delivery system as a vital part of a future state-of-the-art artificial pancreas,\u201d remarked Greg Lamps, SFC\u2019s Vice President of Product Realization.<\/p>\n<p>In July of this year, <a href=\"https:\/\/www.jdrf.org\/press-releases\/sfc-fluidics-inc-announces-partnership-with-jdrf-to-develop-patch-pump-with-open-protocol-communication\/\">JDRF announced<\/a> it will provide funding to SFC for the development of an insulin patch pump with open-protocol communication capabilities. JDRF launched its Open-Protocol Automated Insulin Delivery (AID) Systems Initiative in 2017 with the goal to work with key stakeholders to understand the regulatory and liability implications of an \u201copen-protocol\u201d AID ecosystem \u2013 in which AID components may be seamlessly and safely interoperable \u2013 and moreover to accelerate the delivery of such components to market. The development and delivery to market of a fully interoperable, open-protocol insulin pump is the goal of this JDRF-SFC partnership.<\/p>\n<p>The two-year funding commitment from JDRF enables SFC to accelerate the development and regulatory submission of an open-protocol patch pump system that enable seamless, secure connectivity with other devices (e.g., by using Bluetooth technology) such as interoperable continuous glucose monitors (CGMs) and third-party AID algorithms. Such algorithms may include solutions developed in recent years by the do-it-yourself (DIY) community, a following which is steadily gaining traction.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&hellip;<\/p>\n","protected":false},"author":2,"featured_media":49661,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1437],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes<\/title>\n<meta name=\"description\" content=\"SFC Fluidics announced it has received a $1.4 million grant to develop a patch pump that can deliver both insulin and glucagon to people with Type 1 diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=49651\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Aviad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=49651\",\"url\":\"https:\/\/asweetlife.org\/?p=49651\",\"name\":\"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=49651#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=49651#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg\",\"datePublished\":\"2018-10-02T14:15:20+00:00\",\"dateModified\":\"2019-04-11T08:02:04+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/9f5612f866b93b894ab1ede7211e94c4\"},\"description\":\"SFC Fluidics announced it has received a $1.4 million grant to develop a patch pump that can deliver both insulin and glucagon to people with Type 1 diabetes.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=49651#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=49651\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=49651#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg\",\"width\":2560,\"height\":1708,\"caption\":\"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=49651#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/9f5612f866b93b894ab1ede7211e94c4\",\"name\":\"Michael Aviad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3ba3fc6587a14adc91df0f8eec748ed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3ba3fc6587a14adc91df0f8eec748ed5?s=96&d=mm&r=g\",\"caption\":\"Michael Aviad\"},\"description\":\"Michael Aviad is co-founder of ASweetLife. He was diagnosed with type 1 diabetes in 2002. Michael was born in Santa Barbara and grew up in Jerusalem. He studied law and after passing his bar exam went on to get an MBA with a major in finance. Michael worked for many years as an economist. He and his wife Jess, also a type 1 diabetic, have three sons. Michael loves to run and is always training for the next marathon.\",\"sameAs\":[\"https:\/\/asweetlife.org\/\"],\"url\":\"https:\/\/asweetlife.org\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes","description":"SFC Fluidics announced it has received a $1.4 million grant to develop a patch pump that can deliver both insulin and glucagon to people with Type 1 diabetes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=49651","twitter_misc":{"Written by":"Michael Aviad","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=49651","url":"https:\/\/asweetlife.org\/?p=49651","name":"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=49651#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=49651#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg","datePublished":"2018-10-02T14:15:20+00:00","dateModified":"2019-04-11T08:02:04+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/9f5612f866b93b894ab1ede7211e94c4"},"description":"SFC Fluidics announced it has received a $1.4 million grant to develop a patch pump that can deliver both insulin and glucagon to people with Type 1 diabetes.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=49651#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=49651"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=49651#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/10\/iStock_InsulinPumpBlurred-scaled.jpg","width":2560,"height":1708,"caption":"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=49651#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"NIDDK Funds Development of Dual Hormone Patch Pump for People with Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/9f5612f866b93b894ab1ede7211e94c4","name":"Michael Aviad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3ba3fc6587a14adc91df0f8eec748ed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ba3fc6587a14adc91df0f8eec748ed5?s=96&d=mm&r=g","caption":"Michael Aviad"},"description":"Michael Aviad is co-founder of ASweetLife. He was diagnosed with type 1 diabetes in 2002. Michael was born in Santa Barbara and grew up in Jerusalem. He studied law and after passing his bar exam went on to get an MBA with a major in finance. Michael worked for many years as an economist. He and his wife Jess, also a type 1 diabetic, have three sons. Michael loves to run and is always training for the next marathon.","sameAs":["https:\/\/asweetlife.org\/"],"url":"https:\/\/asweetlife.org\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/49651"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49651"}],"version-history":[{"count":1,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/49651\/revisions"}],"predecessor-version":[{"id":49652,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/49651\/revisions\/49652"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/49661"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}